Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines.

Crow LD, Jambusaria-Pahlajani A, Chung CL, Baran DA, Lowenstein SE, Abdelmalek M, Ahmed RL, Anadkat MJ, Arcasoy SM, Berg D, Bibee KP, Billingsley E, Black WH, Blalock TW, Bleicher M, Brennan DC, Brodland DG, Brown MR, Carroll BT, Carucci JA, Chang TW, Chaux G, Cusack CA, Dilling DF, Doyle A, Emtiazjoo AM, Ferguson NH, Fosko SW, Fox MC, Goral S, Gray AL, Griffin JR, Hachem RR, Hall SA, Hanlon AM, Hayes D Jr, Hickey GW, Holtz J, Hopkins RS, Hu J, Huang CC, Brian Jiang SI, Kapnadak SG, Kraus ES, Lease ED, Leca N, Lee JC, Leitenberger JJ, Lim MA, Longo MI, Malik SM, Mallea JM, Menter A, Myers SA, Neuburg M, Nijhawan RI, Norman DJ, Otley CC, Paek SY, Parulekar AD, Patel MJ, Patel VA, Patton TJ, Pugliano-Mauro M, Ranganna K, Ravichandran AK, Redenius R, Roll GR, Samie FH, Shin T, Singer JP, Singh P, Soon SL, Soriano T, Squires R, Stasko T, Stein JA, Taler SJ, Terrault NA, Thomas CP, Tokman S, Tomic R, Twigg AR, Wigger MA, Zeitouni NC, Arron ST.

Transpl Int. 2019 Sep 10. doi: 10.1111/tri.13520. [Epub ahead of print]

PMID:
31502728
2.

Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study.

Jambusaria-Pahlajani A, Crow LD, Lowenstein S, Garrett GL, Melcher ML, Chan AW, Boscardin J, Arron ST.

Transpl Int. 2019 Aug 19. doi: 10.1111/tri.13493. [Epub ahead of print]

PMID:
31423648
3.

Validation of the English Basal and Squamous Cell Carcinoma Quality of Life (BaSQoL) Questionnaire.

Yu WY, Waalboer-Spuij R, Bremer R, Lu B, Aroyan C, Crow L, Grekin R, Neuhaus I, Yu S, Arron ST, Hollestein LM.

Dermatol Surg. 2019 Aug 6. doi: 10.1097/DSS.0000000000002046. [Epub ahead of print]

PMID:
31397784
4.

Medications Associated with Increased Risk of Keratinocyte Carcinoma.

Crow LD, Kaizer-Salk KA, Juszczak HM, Arron ST.

Dermatol Clin. 2019 Jul;37(3):297-305. doi: 10.1016/j.det.2019.02.005. Epub 2019 Apr 16. Review.

PMID:
31084724
5.

Atypical Fibroxanthoma.

Chapman LW, Yu SS, Arron ST.

Semin Cutan Med Surg. 2019 Mar 1;38(1):E65-E66. doi: 10.12788/j.sder.2019.008.

PMID:
31051027
6.

Performance Measures in Dermatologic Surgery: A Review of the Literature and Future Directions.

Chow C, Yuan JT, Ruiz ES, Soon SL, Makhzoumi Z, Arron ST.

Dermatol Surg. 2019 Jun;45(6):836-843. doi: 10.1097/DSS.0000000000001938. Review.

PMID:
31021903
7.

Reconstruction of a Deep and Wide Sternal Notch Defect After Mohs Micrographic Surgery.

Saylor DK, Yuan JT, Crow L, Arron ST, Carlson EO.

Dermatol Surg. 2019 Feb 15. doi: 10.1097/DSS.0000000000001843. [Epub ahead of print] No abstract available.

PMID:
30829755
8.

Ischemic Fasciitis Mimicking A Lipoma.

Saeed L, Bahrani E, Lauw MIS, Tabatabai ZL, Arron ST, Mauro TM.

Dermatol Surg. 2019 Feb 14. doi: 10.1097/DSS.0000000000001853. [Epub ahead of print] No abstract available.

PMID:
30789504
9.

Mohs Micrographic Surgery in the Veterans Health Administration.

Tam A, Yuan JT, Mauro TM, Dellavalle RP, Arron ST.

Fed Pract. 2018 Feb;35(Suppl 1):S38-S43.

10.

Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.

Gao Y, Twigg AR, Hirose R, Roll GR, Nowacki AS, Maytin EV, Vidimos AT, Rajalingam R, Arron ST.

JAMA Dermatol. 2019 Mar 1;155(3):307-314. doi: 10.1001/jamadermatol.2018.4983.

PMID:
30673077
11.

A randomized phase II study evaluating vismodegib as neoadjuvant treatment of basal cell carcinoma preceding Mohs micrographic surgery: results and lessons learned.

Soon SL, Ibrahim SF, Arron ST.

Br J Dermatol. 2019 Jul;181(1):208-209. doi: 10.1111/bjd.17623. Epub 2019 Apr 1. No abstract available.

PMID:
30628055
12.

Keratinocyte Carcinomas: Current Concepts and Future Research Priorities.

Nagarajan P, Asgari MM, Green AC, Guhan SM, Arron ST, Proby CM, Rollison DE, Harwood CA, Toland AE.

Clin Cancer Res. 2019 Apr 15;25(8):2379-2391. doi: 10.1158/1078-0432.CCR-18-1122. Epub 2018 Dec 6. Review.

PMID:
30523023
13.

Association of Postoperative Antibiotics With Surgical Site Infection in Mohs Micrographic Surgery.

Levin EC, Chow C, Makhzoumi Z, Jin C, Shiboski SC, Arron ST.

Dermatol Surg. 2019 Jan;45(1):52-57. doi: 10.1097/DSS.0000000000001645.

PMID:
30148738
14.

Potential for overlooked melanoma in solid organ donors with a severely dysplastic nevus.

Juszczak H, Lowenstein SE, Crow L, Roll GR, McCalmont TH, Arron ST.

JAAD Case Rep. 2018 Aug 11;4(7):682-683. doi: 10.1016/j.jdcr.2018.04.018. eCollection 2018 Aug. No abstract available.

15.

Characteristics and Skin Cancer Risk Behaviors of Adult Sunless Tanners in the United States.

Dodds M, Arron ST, Linos E, Polcari I, Mansh MD.

JAMA Dermatol. 2018 Sep 1;154(9):1066-1071. doi: 10.1001/jamadermatol.2018.2054.

16.

Response of Cutaneous Squamous Cell Carcinoma to Treatment With Cetuximab.

Berliner JG, Schulman JM, Lazarova Z, Olasz E, Arron ST.

Dermatol Surg. 2019 Feb;45(2):313-316. doi: 10.1097/DSS.0000000000001583. No abstract available.

PMID:
29957662
17.

Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.

Winchester D, Lehman J, Tello T, Chimato N, Hocker T, Kim S, Chang J, Markey J, Yom SS, Ryan W, Mully T, Hodge D, Otley C, Arron ST.

J Am Acad Dermatol. 2018 Nov;79(5):853-859. doi: 10.1016/j.jaad.2018.05.022. Epub 2018 May 19.

PMID:
29787841
18.

Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy.

Xu MJ, Lazar AA, Garsa AA, Arron ST, Ryan WR, El-Sayed IH, George JR, Algazi AP, Heaton CM, Ha PK, Yom SS.

Head Neck. 2018 Jul;40(7):1406-1414. doi: 10.1002/hed.25114. Epub 2018 Mar 10.

PMID:
29524273
19.

Indoor Tanning, Sunless Tanning, and Sun-Protection Behaviors Among Sexual Minority Men.

Gao Y, Arron ST, Linos E, Polcari I, Mansh MD.

JAMA Dermatol. 2018 Apr 1;154(4):477-479. doi: 10.1001/jamadermatol.2018.0003. No abstract available.

20.

Exposed hardware in a patient with invasive keratinocyte carcinoma.

Gao Y, Arron ST, Raymond AK.

JAAD Case Rep. 2017 Dec 20;4(1):101-103. doi: 10.1016/j.jdcr.2017.08.007. eCollection 2018 Jan. No abstract available.

21.

Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma.

Harwood CA, Arron ST, Proby CM, Asgari MM, Bouwes Bavinck JN, Green AC, Toland AE; KeraCon Consortium.

Br J Dermatol. 2017 Nov;177(5):1150-1151. doi: 10.1111/bjd.15932. No abstract available.

PMID:
29192981
22.

Genomic analysis of atypical fibroxanthoma.

Lai K, Harwood CA, Purdie KJ, Proby CM, Leigh IM, Ravi N, Mully TW, Brooks L, Sandoval PM, Rosenblum MD, Arron ST.

PLoS One. 2017 Nov 15;12(11):e0188272. doi: 10.1371/journal.pone.0188272. eCollection 2017.

23.

Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.

Blomberg M, He SY, Harwood C, Arron ST, Demehri S, Green A, Asgari MM; NCI Keratinocyte Carcinoma Consortium.

Br J Dermatol. 2017 Nov;177(5):1225-1233. doi: 10.1111/bjd.15950. Epub 2017 Oct 30. Review.

24.

Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study.

Garrett GL, Yuan JT, Shin TM, Arron ST; Transplant Skin Cancer Network (TSCN).

J Am Acad Dermatol. 2018 Feb;78(2):264-269. doi: 10.1016/j.jaad.2017.09.003. Epub 2017 Oct 12.

PMID:
29031659
25.

Acne, sexual orientation, and mental health among young adults in the United States: A population-based, cross-sectional study.

Gao Y, Wei EK, Arron ST, Linos E, Margolis DJ, Mansh MD.

J Am Acad Dermatol. 2017 Nov;77(5):971-973. doi: 10.1016/j.jaad.2017.06.004. No abstract available.

26.

Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature.

Lowenstein SE, Garrett G, Toland AE, Jambusaria-Pahlajani A, Asgari MM, Green A, Engels EA, Arron ST; National Cancer Institute Keratinocyte Carcinoma Consortium.

Br J Dermatol. 2017 Nov;177(5):1202-1207. doi: 10.1111/bjd.15889. Epub 2017 Sep 26. Review.

PMID:
28952162
27.

Medical marijuana for the treatment of vismodegib-related muscle spasm.

Yuan JT, Tello TL, Hultman C, Barker CA, Arron ST, Yom SS.

JAAD Case Rep. 2017 Sep 1;3(5):438-440. doi: 10.1016/j.jdcr.2017.06.012. eCollection 2017 Sep. No abstract available.

28.

Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib.

Bhutani T, Abrouk M, Sima CS, Sadetsky N, Hou J, Caro I, Chren MM, Arron ST.

J Am Acad Dermatol. 2017 Oct;77(4):713-718. doi: 10.1016/j.jaad.2017.03.038. Epub 2017 Aug 2.

PMID:
28780365
29.

Brief Report: Interleukin-17A-Dependent Asymmetric Stem Cell Divisions Are Increased in Human Psoriasis: A Mechanism Underlying Benign Hyperproliferation.

Charruyer A, Fong S, Vitcov GG, Sklar S, Tabernik L, Taneja M, Caputo M, Soeung C, Yue L, Uchida Y, Arron ST, Horton KM, Foster RD, Sano S, North JP, Ghadially R.

Stem Cells. 2017 Aug;35(8):2001-2007. doi: 10.1002/stem.2656. Epub 2017 Jun 27.

30.

Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin.

Ahn RS, Taravati K, Lai K, Lee KM, Nititham J, Gupta R, Chang DS, Arron ST, Rosenblum M, Liao W.

Sci Rep. 2017 May 2;7(1):1343. doi: 10.1038/s41598-017-01468-y.

31.

Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs.

Wei L, Allain DC, Bernhardt MN, Gillespie JL, Peters SB, Iwenofu OH, Nelson HH, Arron ST, Toland AE.

Br J Dermatol. 2017 Oct;177(4):1066-1073. doi: 10.1111/bjd.15618. Epub 2017 Sep 8.

32.

Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.

Yanik EL, Pfeiffer RM, Freedman DM, Weinstock MA, Cahoon EK, Arron ST, Chaloux M, Connolly MK, Nagarajan P, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):998-1007. doi: 10.1158/1055-9965.EPI-17-0003. Epub 2017 Apr 4.

33.

Mental Artery Occlusion From Poly-L-Lactic Acid Injection at the Lateral Chin.

Yuan JT, Chang TW, Yu SS, Arron ST.

Dermatol Surg. 2017 Nov;43(11):1402-1405. doi: 10.1097/DSS.0000000000001103. No abstract available.

PMID:
28296793
34.

Antimicrobial Prophylaxis for Full-Face Laser Resurfacing in Transplant Recipients.

Hibler BP, Saylor DK, Chin-Hong P, Arron ST.

Dermatol Surg. 2017 Apr;43(4):599-604. doi: 10.1097/DSS.0000000000001044. No abstract available.

PMID:
28291061
35.

Comparing the Quality of Ambulatory Surgical Care for Skin Cancer in a Veterans Affairs Clinic and a Fee-For-Service Practice Using Clinical and Patient-Reported Measures.

Dizon MP, Linos E, Arron ST, Hills NK, Chren MM.

PLoS One. 2017 Jan 31;12(1):e0171253. doi: 10.1371/journal.pone.0171253. eCollection 2017.

36.

Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.

Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, Bibee K, Breithaupt A, Cannon J, Chen A, Cheng JY, Chiesa-Fuxench Z, Colegio OR, Curiel-Lewandrowski C, Del Guzzo CA, Disse M, Dowd M, Eilers R Jr, Ortiz AE, Morris C, Golden SK, Graves MS, Griffin JR, Hopkins RS, Huang CC, Bae GH, Jambusaria A, Jennings TA, Jiang SI, Karia PS, Khetarpal S, Kim C, Klintmalm G, Konicke K, Koyfman SA, Lam C, Lee P, Leitenberger JJ, Loh T, Lowenstein S, Madankumar R, Moreau JF, Nijhawan RI, Ochoa S, Olasz EB, Otchere E, Otley C, Oulton J, Patel PH, Patel VA, Prabhu AV, Pugliano-Mauro M, Schmults CD, Schram S, Shih AF, Shin T, Soon S, Soriano T, Srivastava D, Stein JA, Sternhell-Blackwell K, Taylor S, Vidimos A, Wu P, Zajdel N, Zelac D, Arron ST.

JAMA Dermatol. 2017 Mar 1;153(3):296-303. doi: 10.1001/jamadermatol.2016.4920. Erratum in: JAMA Dermatol. 2017 Mar 1;153(3):357.

PMID:
28097368
37.

Network analysis of psoriasis reveals biological pathways and roles for coding and long non-coding RNAs.

Ahn R, Gupta R, Lai K, Chopra N, Arron ST, Liao W.

BMC Genomics. 2016 Oct 28;17(1):841.

38.

Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma.

Chang AL, Lewis KD, Arron ST, Migden MR, Solomon JA, Yoo S, Day BM, McKenna EF, Sekulic A.

Oncotarget. 2016 Nov 15;7(46):76118-76124. doi: 10.18632/oncotarget.12660.

39.

Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers.

Faden DL, Arron ST, Heaton CM, DeRisi J, South AP, Wang SJ.

J Otolaryngol Head Neck Surg. 2016 Sep 17;45(1):47. doi: 10.1186/s40463-016-0160-4.

40.

Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials.

Chang AL, Arron ST, Migden MR, Solomon JA, Yoo S, Day BM, McKenna EF, Sekulic A.

Orphanet J Rare Dis. 2016 Sep 1;11(1):120. doi: 10.1186/s13023-016-0506-z.

41.

IRF4 Polymorphism Is Associated with Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients: A Pigment-Independent Phenomenon.

Asgari MM, Toland AE, Arron ST.

J Invest Dermatol. 2017 Jan;137(1):251-253. doi: 10.1016/j.jid.2016.07.038. Epub 2016 Aug 24. No abstract available.

42.

Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency.

Reid-Bayliss KS, Arron ST, Loeb LA, Bezrookove V, Cleaver JE.

Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10151-6. doi: 10.1073/pnas.1610020113. Epub 2016 Aug 19.

43.

Research that Guides Clinical Decisions.

Chren MM, Arron ST.

J Invest Dermatol. 2016 Aug;136(8):1535-1537. doi: 10.1016/j.jid.2016.04.031.

44.

Voriconazole exposure regulates distinct cell-cycle and terminal differentiation pathways in primary human keratinocytes.

Mansh M, Ing L, Dimon M, Celli A, Mauro TM, Arron ST.

Br J Dermatol. 2017 Mar;176(3):816-820. doi: 10.1111/bjd.14838. Epub 2017 Jan 17. No abstract available.

45.

Sources and consequences of oxidative damage from mitochondria and neurotransmitter signaling.

Brennan-Minnella AM, Arron ST, Chou KM, Cunningham E, Cleaver JE.

Environ Mol Mutagen. 2016 Jun;57(5):322-30. doi: 10.1002/em.21995. Epub 2016 Jan 14. Review.

PMID:
27311994
46.

Laser hair removal for genital gender affirming surgery.

Zhang WR, Garrett GL, Arron ST, Garcia MM.

Transl Androl Urol. 2016 Jun;5(3):381-7. doi: 10.21037/tau.2016.03.27.

47.

Indoor tanning and melanoma: are gay and bisexual men more at risk?

Mansh M, Arron ST.

Melanoma Manag. 2016 Jun;3(2):89-92. doi: 10.2217/mmt-2015-0002. Epub 2016 May 19. No abstract available.

48.

Comparisons of patients' satisfaction should take expectations into account.

Dizon M, Linos E, Arron ST, Abuabara K, Ruiz de Luzuriaga AM, Jin C, Boscardin WJ, Chren MM.

Br J Dermatol. 2017 Jan;176(1):252-254. doi: 10.1111/bjd.14755. Epub 2016 Dec 7. No abstract available.

PMID:
27203511
49.

Absence of skin cancer in the DNA repair-deficient disease Cockayne Syndrome (CS): A survey study.

Zhang WR, Garrett GL, Cleaver JE, Arron ST.

J Am Acad Dermatol. 2016 Jun;74(6):1270-2. doi: 10.1016/j.jaad.2016.01.003. No abstract available.

PMID:
27185437
50.

Phycosaccharide AI, a mixture of alginate polysaccharides, increases stem cell proliferation in aged keratinocytes.

Charruyer A, Fong S, Yue L, Arron ST, Ghadially R.

Exp Dermatol. 2016 Sep;25(9):738-40. doi: 10.1111/exd.13051. Epub 2016 Jun 15. No abstract available.

PMID:
27095184

Supplemental Content

Loading ...
Support Center